Editorial Guidelines

SemaLiving publishes patient-facing GLP-1 education in a YMYL category. Our editorial standard is safety-first, plain-English, and source-aware.

How content is researched

• Use primary medical and regulatory sources where possible: FDA labels, prescribing information, PubMed, CDC/NIH resources, clinical guidelines, and manufacturer safety pages.
• Verify provider pricing, medication-source language, eligibility rules, and cancellation terms close to publication.
• Flag uncertainty instead of overstating claims.

How content is written

• Write for patients, caregivers, and people preparing for a clinician conversation.
• Avoid “journey,” “wellness,” “transformation,” and vanity weight-loss framing as the dominant tone.
• Use practical language: prescribed, patient, dose, side effects, what is normal, when to call your doctor, and what the research says.

Affiliate and medical boundaries

Affiliate relationships must be disclosed at the top of monetized articles. Educational content must not tell readers to self-prescribe, change doses, ignore side effects, or choose a medication without licensed clinician oversight.